Complementary DNA cloning, functional expression and characterization of a novel cytochrome P450, CYP2D50, from equine liver.

The research involves the discovery and study of a new enzyme called CYP2D50 in horse liver. Despite significant genetic similarity to a human equivalent (CYP2D6), this horse enzyme exhibits notably slower metabolic activity.

Study Objective and Background

• The primary aim of this study was to definitively identify and characterize a member of the CYP2D enzyme family in horses, previously hinted at by equine liver microsome studies. By cloning a cDNA encoding this enzyme and expressing it in a baculovirus system, researchers aimed to better understand this enzyme, its behavior, and its comparative functionality with the human counterpart.

Methodology and Experimental Setup

• A novel CYP2D enzyme (CYP2D50) was cloned from equine (horse) liver and expressed in a baculovirus expression system.
• The nucleotide sequence of the discovered CYP2D50 was compared to that of human CYP2D6 (as they showed high homology), and the activity of the enzyme was characterized using dextromethorphan and debrisoquine, two substrates selectively processed by the human orthologue.
• Optimal catalytic activity with dextromethorphan was evaluated based on different molar ratios of CYP2D50 to NADPH CYP450 reductase, with the best results at a 1:15 ratio.

Findings and Implications

• Even though CYP2D50 and human CYP2D6 share a significant sequence homology, the metabolic activity of the equine enzyme is considerably slower for both substrates tested. Specifically, the researchers discovered that CYP2D50’s dextromethorphan-O-demethylase activity was almost 180 times slower than that of human CYP2D6, and the rates of 4-hydroxydebrisoquine activity formation were 50-fold slower in comparison.
• The study concludes by highlighting the substantial interspecies variability in the metabolism of substrates by CYP2D orthologues.
• These findings underscore the need for comprehensive characterization of this enzyme system in equids (members of the horse family), given their potential roles in drug metabolism, and moreover, because these differences could significantly impact drug efficacy and safety in different species.